Analysis: The peptide problem: Hype is outrunning the evidence McMaster News The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Enforcement Actions and Managing Non Compliance TS Quality & Engineering Compounded "semaglutide" is not FDA approved semaglutide.com FDA to weigh easing limits on unproven peptides promoted by RFK Jr. The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York